Referred pain and hyperalgesia in human tendon and muscle belly tissue.
The sensitivity of tendon and tendon-bone junction is not fully described although these tissues have high clinical impacts. This study assessed (1) pain intensity and referred pain caused by hypertonic saline injection to the proximal tendon-bone junction (PTBJ), tendon and muscle belly sites of tibialis anterior muscle and (2) pressure pain sensitivity, pre, during and post hypertonic saline injections. Eighteen subjects (14 males and 4 females) participated. Subjects also had constant mechanical stimulation for 120s at 130% of baseline pressure pain threshold (PPT) during which VAS parameters were recorded. VAS parameters after hypertonic saline for PTBJ (VAS area, VAS peak), and tendon sites (VAS area, duration and time to maximum VAS) were significantly (P < 0.05) higher than muscle belly. During hypertonic saline pain all three sites displayed local and frequently enlarged and referred pain areas. Hypertonic saline pain at the PTBJ and tendon transiently increased pressure sensitivity at these sites (P < 0.05). When referred pain was caused by mechanical stimulation it occurred predominantly at the PTBJ and tendon sites (86% cases). Constant mechanical stimulation caused steadily increasing pain (summation of pain) at all sites. Hypertonic saline pain at the tendon and PTBJ caused significantly higher (P < 0.001) final VAS scores compared to the muscle belly site. The results indicate the PTBJ and tendon sites are more sensitive and susceptible to sensitisation by hypertonic saline than muscle belly. Furthermore, there may be site specific central changes reflected by the differences in the results regarding sensitivity and summation over time.
Gibson
William
W
Laboratory for Experimental Pain Research, Center for Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 7D-3, DK-9220 Aalborg, Denmark.
Arendt-Nielsen
Lars
L
Graven-Nielsen
Thomas
T
D000328:Adult; D005260:Female; D006801:Humans; D006930:Hyperalgesia / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology*; D007273:Injections, Intramuscular; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000503:physiopathology*; D009209:Myofascial Pain Syndromes / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology*; D010147:Pain Measurement / Q000187:drug effects; D017288:Pain Threshold / Q000187:drug effects; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage; D013710:Tendons / Q000187:drug effects / Q000503:physiopathology*; D014110:Touch
D012462:Saline Solution, Hypertonic